Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Colorado Health Reporter.
Press releases published on May 6, 2025
Drs. Daniel and Richelle Knowles Named Chiropractors of the Year at Sherman College Lyceum
EIN Presswire
·
May 6, 2025
BOULDER, CO, UNITED STATES, May 6, 2025 /EINPresswire.com/ -- Sherman College of Chiropractic proudly honored Drs. Daniel and Richelle Knowles with the prestigious Chiropractor(s) of the Year Award at the 2025 Lyceum. The award, presented during the …
Caroline McKinnon, JD Joins Divorce With Dignity, Launches SW Denver Office for Amicable Divorce Services and Mediation
EIN Presswire
·
May 6, 2025
Attorney …
WellPower Appoints James Greer as CEO
EIN Presswire
·
May 6, 2025
Announcement follows national search; Greer recently served as interim CEO DENVER, CO, UNITED STATES, May 6, 2025 /EINPresswire.com/ -- Today, the Board of Directors for WellPower, Colorado’s largest community mental health center, announced James Greer …
Candela Matrix® Now Available at Montrose Longevity Clinic: Redefining Aesthetic Treatments with Cutting-Edge Technology
EIN Presswire
·
May 6, 2025
Montrose Longevity Clinic is excited to announce the addition of the Candela Matrix®, a state-of-the-art laser system, to their practice. MONTROSE, CO, UNITED STATES, May 6, 2025 /EINPresswire.com/ -- Montrose Longevity Clinic is thrilled to announce …
Omaha Earns First-Ever CityHealth Medal for Advancing Policies that Promote Community Health
GlobeNewswire
·
May 6, 2025
Omaha, Nebraska, May 06, 2025 (GLOBE NEWSWIRE) -- OMAHA – MAY 6, 2025 – Today, CityHealth, an initiative of the de Beaumont Foundation and Kaiser Permanente, awarded the City of Omaha its first overall bronze medal — recognizing the city’s leadership for …
Eupraxia Pharmaceuticals Reports First Quarter 2025 Financial Results
GlobeNewswire
·
May 6, 2025
Data from Phase 1b/2a RESOLVE suggests EP-104GI has significant potential to improve the standard of care for patients with Eosinophilic Esophagitis (EoE) Cash runway to fund operations out to third quarter of 2026 Company to host webinar to discuss …
Dunham House Breaks Ground on Transformational Housing for Combat-Wounded Veterans
GlobeNewswire
·
May 6, 2025
OMAHA, Neb., May 06, 2025 (GLOBE NEWSWIRE) -- Between 2000 and 2019, the Defense and Veterans Brain Injury Center reported nearly 414,000 service members worldwide sustained a traumatic brain injury. In the same period, estimates suggest that between 9% …
WeightWatchers Takes Strategic Action to Eliminate $1.15 Billion of Debt, Strengthening Financial Position for Long-Term Growth and Profitability
GlobeNewswire
·
May 6, 2025
Operations continue with no impact to its more than three million members worldwide Positions the Company to execute its transformation strategy, focused on enhancing its digital and member experience and expanding its telehealth business which achieved …
Extendicare Announces 2025 First Quarter Results
GlobeNewswire
·
May 6, 2025
MARKHAM, Ontario, May 06, 2025 (GLOBE NEWSWIRE) -- Extendicare Inc. (“Extendicare” or the “Company”) (TSX: EXE) today reported results for the three months ended March 31, 2025. First Quarter 2025 Highlights Adjusted EBITDA(1) excluding out-of-period items …
TOMI Environmental Solutions, Inc. to Hold Conference Call to Discuss First Quarter 2025 Financial Results on May 8, 2025
GlobeNewswire
·
May 6, 2025
FREDERICK, Md., May 06, 2025 (GLOBE NEWSWIRE) -- TOMI Environmental Solutions, Inc.® (“TOMI”) (NASDAQ: TOMZ), a global company specializing in disinfection and decontamination solutions, today announced it will report results for the first quarter ended …
BetterLife Announces Debt Settlements
GlobeNewswire
·
May 6, 2025
VANCOUVER, British Columbia, May 06, 2025 (GLOBE NEWSWIRE) -- BetterLife Pharma Inc. (“BetterLife” or the “Company”) (CSE: BETR / OTCQB: BETRF / FRA: NPAU), an emerging biotech company focused on the development of BETR-001, a non-hallucinogenic …
Senti Bio Reports First Quarter 2025 Financial Results and Provides a Corporate Update on Positive SENTI-202 Clinical Development
GlobeNewswire
·
May 6, 2025
Positive Phase 1 data from lead program, SENTI-202, recently presented at the AACR Annual Meeting: SENTI-202 was generally well tolerated, preliminary RP2D identified; 4 of 7 patients achieved composite Complete Remission (cCR) (3 CR, 1CRh), all 4 cCR …
WW International, Inc. Schedules Investor Conference Call
GlobeNewswire
·
May 6, 2025
NEW YORK, May 06, 2025 (GLOBE NEWSWIRE) -- WW International, Inc. (NASDAQ: WW) (“WeightWatchers” or the “Company”), the global leader in science-backed weight management, announced that it will host an investor conference call today May 6, 2025, at 6:00 p. …
LENZ Therapeutics to Participate in Upcoming BofA Securities 2025 Health Care Conference
GlobeNewswire
·
May 6, 2025
SAN DIEGO, May 06, 2025 (GLOBE NEWSWIRE) -- LENZ Therapeutics, Inc. (Nasdaq: LENZ or “LENZ” or the “Company”), a pre-commercial stage biopharmaceutical company focused on the development and commercialization of the first and only aceclidine-based eye drop …
Information regarding the total number of voting rights and total number of shares of the Company as of April 30, 2025
GlobeNewswire
·
May 6, 2025
Information regarding the total number of voting rights and total number of shares of the Company as of April 30, 2025 (Article 223-16 of the General Regulations of the Autorité des Marchés Financiers) Market : NYSE Euronext Paris ISIN Code: FR 0010417345 …
Information relative au nombre total des droits de vote et d’actions composant le capital social au 30 avril 2025
GlobeNewswire
·
May 6, 2025
Information relative au nombre total des droits de vote et d’actions composant le capital social au 30 avril 2025 (Article 223-16 du Règlement Général de l’Autorité des Marchés Financiers) Place de cotation : NYSE Euronext Paris Code ISIN : FR 0010417345 …
Cellectis to Report First Quarter Financial Results on May 12, 2025
GlobeNewswire
·
May 6, 2025
NEW YORK, May 06, 2025 (GLOBE NEWSWIRE) -- Cellectis (the “Company”) (Euronext Growth: ALCLS- NASDAQ: CLLS), a clinical-stage biotechnology company using its pioneering gene-editing platform to develop life-saving cell and gene therapies, today announced …
Lexicon Pharmaceuticals to Present at the 3rd Annual H.C. Wainwright BioConnect Investor Conference
GlobeNewswire
·
May 6, 2025
THE WOODLANDS, Texas, May 06, 2025 (GLOBE NEWSWIRE) -- Lexicon Pharmaceuticals, Inc. (Nasdaq: LXRX) today announced that Company management will participate in a fireside chat at the 3rd Annual H.C. Wainwright BioConnect Investor Conference, taking place …
BioAge Labs Reports First Quarter 2025 Financial Results and Provides Business Updates
GlobeNewswire
·
May 6, 2025
Advancement of lead candidate BGE-102, an oral, brain-penetrant NLRP3 inhibitor for obesity, with initial clinical data expected 2H25 New strategic collaboration with Lilly ExploR…
Leading Independent Proxy Advisory Firm ISS Recommends ACELYRIN Stockholders Vote “FOR” the Proposed Transaction with Alumis
GlobeNewswire
·
May 6, 2025
ACELYRIN Urges Stockholders to Vote FOR the Proposed Transaction Today LOS ANGELES, May 06, 2025 (GLOBE NEWSWIRE) -- ACELYRIN, INC. (Nasdaq: SLRN), a late-stage clinical biopharma company focused on accelerating the development and delivery of …